JOHNSON & JOHNSON

MarketScreener Strategies Johnson & Johnson

Equities

JNJ

US4781601046

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 17:32:29 16/03/2026 GMT			5-day change	1st Jan Change
243.22 ^USD	+0.70%		+0.08%	+17.32%

12:37pm	Monte Rosa Therapeutics Announces Clinical Supply Agreement to Support Phase 2 Trial Evaluating MRT-2359 in Combination with Apalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer	CI
12:36pm	Nasus Pharma Ltd Announces Positive Top Line Data from Phase 2 Clinical Study of NS002	CI

MarketScreener Strategies

Johnson & Johnson: A Dose of Resilience Amid Trade Tensions

Johnson & Johnson: A Dose of Resilience Amid Trade Tensions

April 15, 2025 at 02:53 pm

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

Headlines

J&J CFO Wolk on Orthopedics Spinoff, Earnings, Drug Pricing

J&J CFO Wolk on Orthopedics Spinoff, Earnings, Drug Pricing

October 14, 2025 at 05:20 pm

Johnson & Johnson: A Dose of Resilience Amid Trade Tensions

April 15, 2025 at 02:53 pm

Johnson & Johnson: A Dose of Resilience Amid Trade Tensions

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!

BENEFIT NOW